Neumora Therapeutics, Inc.
Biotechnology company · Watertown, Massachusetts, United States · Nasdaq: NMRA
Neumora Therapeutics, Inc. is a biotechnology company headquartered in Watertown, Massachusetts, United States. Its earliest recorded incorporation is in 2019. Its shares trade on Nasdaq under the ticker NMRA. It has reported private securities offerings to the US SEC, most recently $474 million sold in a notice filed in 2023.
Neumora Therapeutics at a glance
What does Neumora Therapeutics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $474.4 million sold (2023).
Frequently asked questions about Neumora Therapeutics
Where is Neumora Therapeutics headquartered?
Neumora Therapeutics, Inc. is headquartered in Watertown, Massachusetts, United States.
What does Neumora Therapeutics do?
Neumora Therapeutics, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Neumora Therapeutics a public company?
Yes. Neumora Therapeutics, Inc. trades on Nasdaq under the ticker NMRA.
When was Neumora Therapeutics founded?
The earliest incorporation on record for Neumora Therapeutics, Inc. is in 2019, according to public company registers.
Similar companies
- SQZ Biotechnologies CoWatertown, Massachusetts, United States
- Lyndra Therapeutics, Inc.Watertown, Massachusetts, United States
- Arsenal Medical, Inc.Watertown, Massachusetts, United States
- Tectonic Therapeutic, Inc.Watertown, Massachusetts, United States
- Ambergen, Inc.Watertown, Massachusetts, United States
- Vigil Neuroscience, Inc.Watertown, Massachusetts, United States
- Kymera Therapeutics, Inc.Watertown, Massachusetts, United States
- C4 Therapeutics, Inc.Watertown, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-24. Data licences